Business Wire

Kao Revamps Cosmetics Business Strategy to Accelerate Growth

29.9.2025 04:00:00 CEST | Business Wire | Press release

Share

Driving sustainable growth through focused investment in six brands and three overseas expansion models

On September 19, 2025, Kao Corporation (TOKYO:4452) announced a revamp of its Cosmetics Business strategy to accelerate growth. Positioned as a key growth driver within the Kao Group, the Cosmetics Business is targeting net sales of 400 billion yen and an operating margin of 15% at the earliest feasible timing after 2030. As a milestone toward this ambition and in alignment with the medium-term management plan “K27,” Kao will pursue a set of strategic initiatives to drive further expansion.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250928711113/en/

Six focus brands of Kao Cosmetics

  • Kao will divide the six brands poised for global growth into three distinct overseas expansion models, sharpening brand positioning and enhancing competitiveness in the global market.
  • Leveraging its broad technological assets as a diversified chemical manufacturer, Kao will apply its distinct fundamental technologies across categories and brands.
  • By integrating human expertise with AI, the company will maximize sales capabilities, further streamline supply chain management, and reduce fixed costs to strengthen business foundation.

Growth Strategy for Six Focus Brands

Kao will position SENSAI, MOLTON BROWN, KANEBO, SOFINA, Curél, and KATE as its focused global growth brands. The company will accelerate overseas expansion in markets where these brands address consumer needs and can leverage Kao’s extensive resources and expertise.

Japan-Origin model:

Curél, Japan's number one brand for sensitive skin care*1, is accelerating its expansion in the European market. Backed by more than 40 years of expertise in dry, sensitive skin and over 25 years of ceramide research, Curél entered Europe in 2019 and has since gained strong traction. In the first half of 2025, sales in the UK rose 70% year-on-year, underscoring robust demand. Leveraging the proven efficacy of its “ceramide care,” Kao will expand Curél’s store presence in Europe by six times, with a goal of generating 50% of total brand sales outside Japan by 2027.
*1 INTAGE SRI+ Sensitive Skin Care Market – Value Share, July 2024 to June 2025

Europe-Origin Model:

Kao is expanding its luxury brands SENSAI and MOLTON BROWN, both of which embody distinctive aesthetics and philosophies that have strongly resonated with consumers in Europe’s luxury segment. The strategy now focuses on capturing growth in the rapidly expanding Asian luxury market. Through “Integrated operations” that manages Asia as one market for global shoppers, Kao aims to increase SENSAI sales in Asia (including Japan) by 150% and MOLTON BROWN sales by 100% by 2027, compared with 2024 levels.

Asia Model:

This model adapts brand values developed in Japan to meet the unique characteristics of Asian markets. Thailand, with its strong cultural affinity to Japan in areas such as makeup and anime, will serve as the pilot market. Kao will concentrate on the KANEBO and KATE brands to establish a successful blueprint for regional rollout, targeting sales growth of 150% in Thailand by 2027 compared with 2024 levels. In parallel, Kao will reposition SOFINA, unifying its sub-brands under the SOFINA umbrella. Since its establishment in 1982, SOFINA has built a strong presence in Japan with its science-driven approach to skincare and makeup. By 2027, Kao aims to increase SOFINA sales in Asia (excluding Japan) by approximately 50%.

Improving Soundness by Enhancing Earning Power and Streamlining Fixed Costs

Kao will reinforce profitability and long-term growth by focusing resources on the six brands, while also strengthening business foundation.

The company plans to implement its fundamental technologies across various brands and categories. By integrating its extensive technological assets—spanning dermatology, bioscience, chemicals, and production processes—Kao will achieve effective investment by sharing of strong technology-driven differentiation. This strategy is unique to a diversified chemical manufacturer like Kao.

Additionally, by leveraging the expertise of its workforce and incorporating digital capabilities and artificial intelligence, Kao intends to maximize sales potential and enhance supply chain management efficiency. This will lead to further fixed cost reductions and establish a more resilient business structure.

Leadership and Vision

These initiatives will be led by Tomoko Uchiyama, Executive Officer and President of Global Consumer Care - Cosmetics Business, who assumed her role in January 2025. Having successfully transformed Kao’s hair care business, Uchiyama will now apply her expertise to drive the growth and renewal of the Cosmetics Business.

Uchiyama commented:
“Our Cosmetics Business has the flexibility to respond to changing times and market dynamics with a diverse portfolio of brands. By combining this agility with the broad and solid foundation of the Kao Group, we will serve as a pioneer within the company in advancing globalization and accumulating expertise. To that end, we will pursue a strategy centered on the six brands, aiming to establish a strong earnings base by 2027 through both growth initiatives and structural reforms. Building on this foundation, we will target sustainable growth beyond, striving to achieve ‘Global Sharp Top’ with a brand portfolio that blends scientific evidence with sensorial beauty.

About Kao

Kao, a Japan-based manufacturer of personal care and household products, cosmetics, and specialty chemicals creates high-value-added products and services that provide care and enrichment for the life of all people and the planet. Through its brands such as Attack laundry detergent, Bioré and Jergens skin care products, Laurier sanitary products, Curél, SENSAI, and MOLTON BROWN cosmetics, and Oribe hair care products, Kao is part of the everyday lives of people across Asia, the Americas, Europe, the Middle East, and Africa. Combined with its chemical business, which contributes to a wide range of industries, Kao generates about 1,630 billion yen in annual sales. Kao employs about 32,600 people worldwide and has more than 130 years of history in innovation. As an enterprise that provides products people use on a daily basis, the Kao Group takes responsibility to actively reduce the environmental footprint of its products throughout the product lifecycle. This is laid out in Kao’s ESG strategy, the Kirei Lifestyle Plan, which launched in 2019.
Please visit the Kao Group website for additional information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250928711113/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease1.5.2026 23:28:00 CEST | Press release

Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi®(ruxolitinib)Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily JakafiJakafi XR will be available for pharmacy orders by May 8 Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meetin

Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 18:08:00 CEST | Press release

Drivers and team members of Formula 1® were reunited with their loved ones during a night that also celebrated the new partnership between Barilla and the Visa Cash App Racing Bulls Formula 1® Team. A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines wer

TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press release

Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the

Andersen Consulting styrker sine kompetencer inden for digital transformation med Weexa1.5.2026 10:07:00 CEST | Pressemeddelelse

Andersen Consulting indgår en samarbejdsaftale med Weexa, en global leverandør af løsninger inden for digital transformation, B2B-integration og digitalisering af forsyningskæden. Med hovedsæde i Frankrig leverer Weexa end-to-end-tjenester, der hjælper organisationer med at optimere, sikre og skalere deres digitale økosystemer. Virksomheden specialiserer sig i styring af B2B-datastrømme og digitalisering, hvilket muliggør problemfri kommunikation mellem applikationer både internt og på tværs af organisationer gennem teknologier som EDI, API'er og e-fakturering. Weexa tilbyder også SAP-integration og supply chain-løsninger til styring af lager og transport, sideløbende med strategisk rådgivning, projektlevering og vedligeholdelse af tredjepartsapplikationer. Weexa betjener organisationer inden for fødevaresektoren, detailhandel, engros, logistik, transport, bilindustrien, sundheds- og mediesektoren og hjælper globale virksomheder med at optimere deres ydeevne samt at overholde de nyeste

Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press release

Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye